Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Defense & Aerospace

Lockheed Martin Boosts Investor Returns Amid Major Defense Contracts

Andreas Sommer by Andreas Sommer
October 13, 2025
in Defense & Aerospace, Dividends, Earnings
0
Lockheed Martin Stock
0
SHARES
13
VIEWS
Share on FacebookShare on Twitter

Lockheed Martin has unveiled a significant capital return initiative for shareholders, combining an increased dividend with expanded stock repurchases. The defense contractor’s board approved a quarterly dividend of $3.45 per share on October 9, representing a $0.15 increase from the previous quarter and marking a 5 percent rise in shareholder distributions.

This dividend enhancement continues Lockheed Martin’s remarkable track record of returning value to investors, representing the company’s twenty-third consecutive annual dividend increase. Beyond the raised payout, directors authorized an additional $2 billion for share repurchases, bringing the total available for future buyback programs to approximately $9.1 billion.

Major Defense Contracts Underpin Financial Strength

The substantial return of capital to shareholders coincides with Lockheed Martin securing defense agreements totaling over $12 billion. The Pentagon announced a contract modification valued at $12.5 billion for production of 148 F-35 fighter aircraft. This arrangement covers final procurement for Lot 18 alongside advance work for Lot 19, with deliveries scheduled to commence in 2026.

Should investors sell immediately? Or is it worth buying Lockheed Martin?

In a separate development, the U.S. Army cleared the Precision Strike Missile (PrSM) for full-rate production. Lockheed Martin is preparing to scale manufacturing capacity to as many as 400 missiles annually, positioning the company to capitalize on expanding demand for precision weaponry.

Strategic Timing Ahead of Quarterly Results

These announcements come ahead of Lockheed Martin’s third-quarter earnings release scheduled for October 21. Following a challenging second quarter that included significant program charges, the company’s latest moves signal management confidence in future cash flow generation. Market analysts project earnings of approximately $6.33 per share for the upcoming report.

The simultaneous timing of generous shareholder returns and substantial contract awards raises questions about whether these developments reflect genuine operational strength or strategic positioning ahead of potentially mixed quarterly performance. The company’s actions demonstrate a clear commitment to shareholder value, though the underlying motivation remains subject to interpretation within the investment community.

Ad

Lockheed Martin Stock: Buy or Sell?! New Lockheed Martin Analysis from March 25 delivers the answer:

The latest Lockheed Martin figures speak for themselves: Urgent action needed for Lockheed Martin investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Lockheed Martin: Buy or sell? Read more here...

Tags: Lockheed Martin
Andreas Sommer

Andreas Sommer

About Andreas Sommer Over 40 years of expertise in market analysis, chart technical analysis, and strategic investment advisory. With more than four decades of experience in banking and financial journalism, Andreas Sommer is recognized as one of the leading analysts in the German-speaking market. His deep understanding of market dynamics and technical analysis has helped countless investors navigate complex financial markets.
Areas of Expertise:
  • Technical Chart Analysis
  • Strategic Investment Advisory
  • Market Trend Analysis
  • Financial Journalism
Andreas brings unparalleled insights from his extensive career in banking and financial markets, making him a trusted voice for investors seeking professional guidance.

Related Posts

Unitedhealth Stock
Analysis

UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

March 25, 2026
Intel Stock
Analysis

Intel’s Capital Reshuffle and Leadership Transition Revealed in Annual Filing

March 25, 2026
SPDR® S&P® U.S. Dividend Aristocrats UCITS ETF (Dist) Stock
Dividends

A Quarterly Review of the SPDR S&P U.S. Dividend Aristocrats ETF

March 24, 2026
Next Post
Oracle Stock

Oracle's AI Ambitions Face Critical Test at Upcoming Conference

Coinbase Stock

Coinbase Poised to Bridge Traditional Finance and Crypto with Native Token Launch

Salesforce Stock

Salesforce Bets Big on AI to Reignite Growth Momentum

Recommended

E.ON Stock

E.ON’s Strong Performance Meets Regulatory Uncertainty

2 weeks ago
Global X MSCI Argentina ETF Stock

Argentina’s ETF: A Fragile Recovery Fueled by US Support?

6 months ago
Red Cat Stock

Military Contract Ignites Rally for Red Cat Shares

5 months ago
Bitcoin Stock

Bitcoin’s Rebound: A Sustainable Recovery or Bull Trap?

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Intel’s Capital Reshuffle and Leadership Transition Revealed in Annual Filing

35,000 Guards for 359 Million Doors: The Cyber Deficit Wall Street Can No Longer Ignore

Palo Alto Networks Finalizes Debt Terms Following CyberArk Acquisition

Kuya Silver Shares Show Signs of Technical Recovery

VanEck’s Junior Gold ETF Overhauls Holdings with Major Additions

Southern Silver Exploration Advances Key Mexican Project to Next Stage

Trending

Ocugen Stock
Analysis

Ocugen Shares Tumble Despite Positive Clinical Trial Results

by Rodolfo Hanigan
March 25, 2026
0

In a surprising market reaction, shares of biotechnology firm Ocugen experienced a significant sell-off this week, even...

Coinbase Stock

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

March 25, 2026
Unitedhealth Stock

UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

March 25, 2026
Intel Stock

Intel’s Capital Reshuffle and Leadership Transition Revealed in Annual Filing

March 25, 2026
35,000 Guards for 359 Million Doors: The Cyber Deficit Wall Street Can No Longer Ignore

35,000 Guards for 359 Million Doors: The Cyber Deficit Wall Street Can No Longer Ignore

March 24, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Ocugen Shares Tumble Despite Positive Clinical Trial Results
  • Regulatory Proposal Sparks Sell-Off in Coinbase Shares
  • UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com